Newsroom

DENVER--(BUSINESS WIRE)--Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the third quarter ended September 30, 2026. “We delivered record financial results again in the third quarter, with revenue in each of our markets growing sequentially and year-over-year,” said Steve Kelley, president and CEO of Advanced Energy. “Our strategic investments and solid executio...

BOCA RATON, Fla.--(BUSINESS WIRE)--SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended September 30, 2026. Highlights of the third quarter include: Net income attributable to SBA of $231.3 million or $2.19 per share Industry-leading AFFO per share of $3.19 Repurchased 1.7 million shares throughout the quarter Established a $2.5 billion commercial paper program Sold all towers in Chile and Ecuador and entered into an agreement to se...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2026, and raised its full year 2026 revenue guidance. “Vertex delivered excellent third quarter results marked by strong revenue growth across the increasingly diversified portfolio, continued advancement of the R&D pipeline, and the successful close of the Crinetics Pharmaceuticals acquisition,” said Reshma Kewalramani, M.D., Ch...

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its third quarter 2026 financial results and provided a corporate update. “Strong execution across our business drove another quarter of significant growth, with FILSPARI net product sales of $200 million for the quarter as we continued to expand our reach in IgAN and FSGS,” said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. “We remain early in reaching the more than 100,000 a...

EAGLE, Idaho--(BUSINESS WIRE)--Lamb Weston Holdings, Inc. (NYSE: LW), a global leader in frozen potato products, today announced its participation in two investor conferences in November 2026.The Company will participate in the following events:J.P. Morgan U.S. Opportunities Forum – November 13, 2026. Lamb Weston will participate in a fireside chat and one-on-one meetings.Stephens Annual Investment Conference – November 19, 2026. Lamb Weston will participate in a fireside chat at 9:30 a.m. CT an...

NEW YORK--(BUSINESS WIRE)--AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi”), a leading independent global wealth manager with approximately $96 billion in assets, today announced it will release its financial results for the third quarter of 2026 after the market close on Monday, November 9, 2026. Management will host a conference call and webcast the same day at 5:00pm Eastern Time to provide a business update and discuss the financial results for the quarter. Conference Call Information Participants...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2027 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to un...

HILLSBORO, Ore.--(BUSINESS WIRE)--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable and platform firmware leader, announced financial results today for the fiscal third quarter ended October 3, 2026. Lattice completed the acquisition of AMI on July 27, 2026 (the “acquisition date”). Lattice’s results for the third quarter of fiscal 2026 include AMI’s results from the acquisition date, while the prior periods presented do not. Revenue for the third quarter of 2026 was...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced positive topline results from the Phase 3 RedeS (NCT03037164) trial. “Over the past decade, pathogen reduction technology has become an integral component of the blood safety toolkit. The topline results from the RedeS study reinforce the potential to extend this established paradigm to red blood cell transfusions,” said Ross M. Fasano, MD, Professor of Pathology & Laboratory Medicine and Hematology at Emory...

NEW YORK--(BUSINESS WIRE)--E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, which indicates whether clients were net buyers or sellers in each of the 11 core stock market sectors defined by the Global Industry Classification Standard (GICS). These figures, which encompass activity in all US-traded stocks (including OTC) and ADRs, reflect purchases and sales of the individual stocks in each sector, as well as dividend investments and options exercises a...